Small molecule inhibitors targeting m6A regulators

G Feng, Y Wu, Y Hu, W Shuai, X Yang, Y Li… - Journal of Hematology & …, 2024 - Springer
As the most common form of epigenetic regulation by RNA, N6 methyladenosine (m6A)
modification is closely involved in physiological processes, such as growth and …

Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements

X Fei, J Wu, H Tian, D Jiang, H Chen, K Yan… - Cancer …, 2024 - content.iospress.com
Glioma is the most common primary tumor of the central nervous system (CNS).
Glioblastoma (GBM) is incurable with current treatment strategies. Additionally, the treatment …

Single-cell transcriptomics reveals the interaction between peripheral CD4+ CTLs and mesencephalic endothelial cells mediated by IFNG in Parkinson's disease

S Yan, Y Si, W Zhou, R Cheng, P Wang, D Wang… - Computers in Biology …, 2023 - Elsevier
Parkinson's disease (PD) is characterized by dopaminergic neurons degeneration in the
substantia nigra pars compacta. Increasing evidence indicates that peripheral CD4+ T cells …

ptx3a+ fibroblast/epicardial cells provide a transient macrophage niche to promote heart regeneration

J Sun, EA Peterson, X Chen, J Wang - Cell reports, 2024 - cell.com
Macrophages conduct critical roles in heart repair, but the niche required to nurture and
anchor them is poorly studied. Here, we investigated the macrophage niche in the …

The potential impact of HNRNPA2B1 on human cancers prognosis and immune microenvironment

T Huang, G Zhu, F Chen - Journal of Immunology Research, 2024 - Wiley Online Library
HNRNPA2B1 is a member of the HNRNP family, which is associated with telomere function,
mRNA translation, and splicing, and plays an important role in tumor development. To date …

[HTML][HTML] Prognosis and immunoinfiltration analysis of angiogene-related genes in grade 4 diffuse gliomas

H Liu, Z Zeng, P Sun - Aging (Albany NY), 2023 - ncbi.nlm.nih.gov
Although angiogenesis critically influences the progression of solid tumors, its contribution to
highly malignant, grade 4 diffuse gliomas remains unclear. After analyzing 506 …

m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent

J Kong, S Lu, L Zhang, Y Yao, J Zhang, Z Shen… - Frontiers in …, 2022 - frontiersin.org
Purpose Immune checkpoint blockade agents were shown to provide a survival advantage
in urothelial carcinoma, while some patients got minimal benefit or side effects. Therefore …

The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway

JJ Chen, TZ Lu, T Wang, WH Yan, FY Zhong… - Cell Death & …, 2024 - nature.com
Glioma is the most common and aggressive type of primary malignant brain tumor. The N6-
methyladenosine (m6A) modification widely exists in eukaryotic cells and plays an important …

[HTML][HTML] The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma

L Liu, L Han, L Dong, Z He, K Gao, X Chen, JC Guo… - PeerJ, 2023 - peerj.com
Background Lung adenocarcinoma (LUAD) is a common lung cancer with a poor prognosis
under standard chemotherapy. Hypoxia is a crucial factor in the development of solid …

Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma

A Kobayashi, Y Kitagawa, A Nasser, H Wakimoto… - Cells, 2024 - mdpi.com
Despite a long history of research, neurodegenerative diseases and malignant brain tumor
gliomas are both considered incurable, facing challenges in the development of treatments …